Summary

Cow’s milk (CM) is a nutrition-rich (proteins, calcium, vitamins, and energy) food typically consumed after processing. Globally, CM is one of the foods popularly consumed by infants, children, and adults. However, allergy to CM is prevalent among infants and young children during the first year of life, affecting 0.5-3% at the age of 1 year. Dairy products based on milk (such as cheese, butter, cream, and yogurt) or baked milk products (such as baked muffins and pizza) are also consumed worldwide. The major allergens found in CM are casein in milk coagulum, α-lactalbumin, and β-lactoglobulin in milk whey. Casein possesses a high degree of allergenicity and antigenicity compared to whey proteins and is a heat-stable protein resistant to processing. On the contrary, whey proteins in milk allergens are reported to be heat labile and affected by processing. Milk sensitization is regarded as a prerequisite for immunoglobulin E (IgE)-mediated milk allergy and is found to be more prevalent than milk allergy. Clinical manifestations of CM allergy (CMA) can be both IgE-mediated [like anaphylaxis, cutaneous reactions, angioedema, urticaria, vomiting, aggravation of atopic dermatitis, gastrointestinal (GI) symptoms, asthma, allergic rhinitis, and rhinoconjunctivitis] and non-IgE mediated (GI symptoms like diarrhea, reflux, abdominal discomfort, mucus, blood in the stool, vomiting, etc.) reactions. Therefore, milk-allergic individuals are recommended to avoid milk and milk-based products in their diet. Additionally, oral immunotherapy might be an effective treatment option for young children with CMA. Most milk-allergic infants are reported to develop clinical tolerance naturally towards CM by 5 years. Moreover, the development of CM tolerance has been reported in children after the early introduction of CM protein as a supplement to breastfeeding during weaning and also by introducing baked-milk products into the diet of children with CMA. An oral food challenge is considered the gold standard for diagnosing CMA. Moreover, milk sIgE testing is also used as an aid in diagnosing milk allergy and monitoring disease development. Persistent sensitization to milk has been regarded as a strong predictor for the later development of aeroallergen sensitization and respiratory diseases in pediatrics. Furthermore, CM has been found to be cross-reactive with buffalo, sheep, camel, goat, mare, and donkey milk; CM-based products has also been reported to be cross-reactive with beef, and cow dander.

Epidemiology

Worldwide distribution

Allergy to CM is prevalent among infants and young children during the first year of life, affecting 0.5-3% at the age of 1 year. However, the estimated prevalence of cow milk allergy (CMA) may differ based on variations in study populations, geographical location, clinical history of the patient, IgE testing, oral food challenge (OFC), or self-reporting of allergy.

A systematic review involving 42 studies on CMA in Europe reported the prevalence of CMA to be 1.6% across all age groups (based on OFC or history of CMA). Another review study reported the overall prevalence of CMA to be 0.9% and a country-wise prevalence of 1.8% in the United States (US) (1-5 years), 2.9% (3 years) in the United Kingdom, and 0.5% (3-5 years) in Israel. The average prevalence of confirmed CMA among children (during the first two years) in Europe was found to be 0.54% in a Europe-based multicenter study conducted on 12,049 children (≤ 2 years). Furthermore, the self-reported prevalence of milk allergy in food-allergic children (of all ages) was found to be 21.1% (702/3339) in a US-based cross-sectional survey. A Korean study involving 1353 children and adolescents (0-18 years) reported CM to be one of the most frequent (28.1%) causes of immediate food-allergic reactions.

Sensitization of milk refers to the production of IgE antibodies towards milk proteins and is a prerequisite for developing symptoms and an IgE-mediated milk allergy. Therefore, milk sensitization is the first step toward developing milk allergy and is often more prevalent. IgE sensitization has been detected in very young age groups. A Nordic population-based cohort study reported the prevalence of milk sensitization among 3-month-old infants to be 2.5% (27/1100). A population-based study conducted in the US on 8203 participants with serological data (aged 1 to >60 years) reported the overall prevalence of milk sensitization to be 5.7%. Furthermore, the highest (22%) sensitization of milk was observed among children aged 1-5 years. In a recent multicenter (China, Russia, and India) epidemiological study, the rate of sensitization to milk among children (6-11 years) was reported to range between 1.2% (Russia) to 6.7% (in China).

The natural history of milk allergy

Cow milk allergy has been reported as one of the frequent food allergies affecting children during the first ten years of life. Typically, CMP allergy has been reported to be initiated during the neonatal stage, then peaks during the first year of life, followed by a resolution of symptoms and a spontaneous development of tolerance and outgrowth of the milk allergy later in childhood or early adolescence. Most (approx. 80%) of milk allergic infants develop clinical tolerance naturally within 5 years.

According to a birth cohort study conducted in the Isle of Wight on 1456 patients, a decrease in CMA prevalence has been observed with increased age. The highest (3.5%) prevalence of CMA was found during the first year of life, while the lowest (0.3%) was seen at age 18 years. Similarly, in another study, the prevalence of CM sensitization was found to be 8.7% in 1-year-old children, whereas <5% among 18-year-old children.

Risk factors

According to a review study, high-risk populations such as individuals with atopic diseases and multiple food allergies might be prone to CMA. Other CMA-associated risk factors are family history and ethnicity/race. CMA has also been observed to be more prevalent among male children compared to females, whereas this situation reverses during adulthood.

Furthermore, rare cases of allergic reactions (urticaria, angioedema, etc.) mediated by lactose-containing pharmaceutical products (including dry powder inhalers with fluticasone/salmeterol, methylprednisolone sodium succinate injections) have been reported in individuals with CMA.

Pediatric issues

In infants, besides breast milk, breast milk substitute formulas are often the first food introduced to the baby's diet in cases where breastfeeding is insufficient/not possible and later during weaning. Exclusively breastfed infants are usually reported to develop only mild-to-moderate reactions toward CMP and rarely life-threatening symptoms.

Persistent sensitization to milk and egg is a strong predictor for later development of aeroallergen sensitization and respiratory diseases such as allergic rhinitis and allergic asthma.

Route Of Exposure

Ingestion (consumption) of CM or dairy products is considered the main route of exposure.

Clinical Relevance

Cow milk allergy is considered one of the most common pediatric food allergies. Milk allergy can be either IgE-mediated or non-IgE-mediated. Generally, the allergic reactions to CMP are IgE-mediated and manifest immediate symptoms (shortly after consumption), whereas the non-IgE mediated reactions are usually delayed reactions (after hours or days of consumption). The immediate IgE-mediated reactions mainly lead to angioedema, urticaria, aggravation of atopic dermatitis (AD), vomiting, respiratory symptoms, and in some cases, anaphylaxis. Symptoms of delayed reactions might include AD or gastrointestinal (GI) symptoms like enteropathy or proctocolitis.

Anaphylaxis

Anaphylaxis due to CMA is considered an immediate (usually within minutes to a few hours) response developed after consuming CM or milk products and is regarded as potentially life-threatening.

An OFC study on CMA children (median age 1.3 years) detected anaphylaxis in 4% (8/215) of children following the consumption of CM.

According to the European Anaphylaxis Registry, CM was reported to elicit anaphylaxis in 128 individuals (preschoolers, children, and adolescents) out of 1565 patients (with known elicitors of anaphylaxis). Furthermore, a Thailand-based study conducted on 73 patients with food-induced anaphylaxis reported CM as one of the triggers of anaphylaxis in 11% of the patients.

Cutaneous reactions

Cutaneous reactions are reported as one of the most common immediate reactions to milk in children, observed in more than half of the CMA children and might result in conditions like angioedema, urticaria, acute pruritis, etc.

An OFC test conducted on CMA children (median age 1.3 years) observed that 99% (213/215) of children and 4% (9/215) of children exhibited cutaneous and mucous membrane reactions, respectively, with CM.

Gastrointestinal symptoms

GI symptoms have been found to be one of the most frequent CMA-associated reactions. According to a review study, about 50-60% of children with CMA are found to exhibit GI symptoms. CMA-related GI symptoms can be either IgE-mediated, non-IgE mediated, or a combination of both.

Patients with CMA might experience vomiting immediately after consumption of CM. Diarrhea is reported as a delayed response; however, in some instances, it can also be an immediate response. Additionally, abdominal or colic pain has also been reported.

An OFC study on CMA children (median age 1.3 years) reported that 7% (14/215) of children developed GI symptoms towards CM.

Atopic Dermatitis

Atopic dermatitis is a chronic, inflammatory skin disease typically related to allergic sensitization. A study reported that around one-third of the pediatric population with AD (moderate to severe) is allergic to food, which further affects AD progression. In addition, studies from different countries revealed that CM could be considered one of the major allergenic foods in children with AD.

In a prospective Danish birth cohort study on 553 newborns, 11% (61/553) were diagnosed with AD [IgE and skin prick test (SPT)-based], and 26% (16/61) among them were sensitized to CM.

Moreover, the severity of AD (eczema) in infants may depend on the age of onset (early-onset results in severe condition) and the level of specific IgE (sIgE) towards CM (higher level leads to severity).

A prospective analysis of 100 infants with CMA (average age 8.74 months) detected AD in 71 of them. These AD patients showed elevated sIgE levels for CM at different ages compared to non-AD patients; particularly at 6 months, the sIgE was highest.

Allergic rhinitis and rhino-conjunctivitis

Milk protein-associated respiratory allergy (such as acute rhinitis and/or conjunctivitis) is rarely prevalent among adults and, in some cases, related to occupational allergy. Moreover, a review study on children with CMA reported around 20-30% prevalence of respiratory symptoms among the patients.

A study has reported CMA-mediated clinical manifestations of respiratory symptoms like sneezing, acute rhino-conjunctivitis along with watery nasal secretion, and tearing.

Asthma

A study in Spain reported higher sIgE levels against CM among 83% (5 out 6) of children with asthma experiencing severe accidental allergic reactions. Moreover, a Portugal-based study also reported asthma as a predictive factor for the persistence of CMA in 51.2% of 82 children (> 2 years and tolerated CM beyond that age or persisted with CMA until the study’s end).

Other diseases

Non-IgE mediated reactions

Individuals with suspected CMA symptoms have been found to possess mild-moderate-severe non-IgE mediated clinical reactions toward CM. The manifestations of GI symptoms (such as colic pain or irritability, vomiting, diarrhea, reflux, abdominal discomfort, mucus, or blood in the stool) usually occur within 2-72 hours post-consumption of CMP. Moreover, skin reactions, including erythema, pruritis, moderately persistent AD, and non-specific rashes, have also been reported as non-IgE-mediated allergic reactions toward CMP.

Lactose intolerance is a non-immunogenic condition with a diminished ability to digest lactose due to a deficiency of lactase (enzyme). The common symptoms of lactose intolerance include abdominal discomfort, flatulence, diarrhea, bloating, etc. Non-IgE mediated CMA is often confused with lactose intolerance and may lead to a needlessly restricted diet.

Diagnostics

Challenge tests

An OFC is regarded as the gold standard for diagnosing CMA. However, OFC is often considered time-consuming, resource-intensive, and potentially risky.

In-vitro diagnostics

Milk sIgE testing is used as an aid in diagnosing milk allergy and monitoring disease development. Using sIgE diagnostic values has been reported to be beneficial for physicians in deciding when and how it is necessary to perform an OFC to estimate the potential risk of CMA to the patient´s health. In addition, monitoring of reduction in sIgE levels can also be beneficial in predicting the development of tolerance towards CM among children with CMA, further confirmed by OFC tests.

In patients with persistent milk allergy, milk sIgE levels are found to be higher in the first two years of life compared to those developing tolerance. This was further evident from a study conducted on 115 children (< 24 months; with AD and CMA), which reported a progressive reduction of CM sIgE in serum of patients developing milk tolerance (about 50% of children of age > 24 months became tolerant to CM by 67 months of age) compared to the patients with persistent milk allergy.

Prevention And Therapy

Allergen immunotherapy

Various studies have reported oral immunotherapy (OIT) as an effective treatment option for young children with CMA. The European Academy of Allergy and Clinical Immunology (EAACI) guideline on OIT in food allergy suggests starting CM OIT in children around 4-5 years old because, at this age, 50-90% of the children have already outgrown their allergy. Also, the EAACI Molecular Allergology User´s Guide proposes that molecular diagnosis may be utilized to identify subjects at higher risk of experiencing side effects from milk OIT and to monitor the development of desensitization and tolerance.

For example, a milk-based OIT study conducted on 76 patients (with persistent CMA) reported that 72% (55/76) of patients developed tolerance and attained the target maintenance dose (200 ml) for CM during OIT. Moreover, the study revealed high levels of the milk allergen components like α-lactalbumin, β-lactalbumin and casein before OIT starts could predict a less successful OIT outcome with a lower maintenance dose reached.

Prevention strategies

Complete elimination (avoidance) of milk and milk-based products from the diet is considered the main treatment for CMA. However, complete avoidance of proteins present in cow´s milk might adversely impact the growth and development of infants or children. Hence, for infants with CMA, breastfeeding (if possible) and/or alternative formula (like hydrolyzed or amino acid-based formula or soy formula) should be considered as a source of nutrition.

Furthermore, CMA patients are usually recommended to avoid other mammalian milk, like goat’s milk and sheep’s milk, owing to the presence of highly cross-reactive allergenic molecules.

Early introduction of CMP as a supplement to breastfeeding and during weaning might be beneficial in developing tolerance towards CM. Additionally, the introduction of baked-milk products (muffins, bread, and cakes) in the diet of children with CMA has been reported to enhance milk tolerance and is even considered a positive treatment alternative for patients with CMA.

Author: Turacoz Healthcare Solutions

Reviewer: Dr. Eva Södergren

Agyemang, A., S. Saf, T. Sifers, M. Mishoe, M. P. Borres, H. A. Sampson and A. Nowak-Wegrzyn (2019). "Utilizing boiled milk sIgE as a predictor of baked milk tolerance in cow's milk allergic children." J Allergy Clin Immunol Pract 7: 2049-2051.

Alduraywish, S. A., C. J. Lodge, D. Vicendese, A. J. Lowe, B. Erbas, M. C. Matheson, J. Hopper, D. J. Hill, C. Axelrad, M. J. Abramson, K. J. Allen and S. C. Dharmage (2016). "Sensitization to milk, egg and peanut from birth to 18 years: A longitudinal study of a cohort at risk of allergic disease." Pediatr Allergy Immunol 27: 83-91.

Anna Nowak-Wegrzyn, A. M. (2016). "B10 – Cow’s Milk Allergy " Peadiatric Allergy and Immunology. EACCI. MOLECULAR ALLERGOLOGY USER’S GUIDE.P M. Matricardi, J. Kleine-Tebbe. 27: 95-99.

Bernard, H. (1999). "IgE Cross-reactivity with Caseins from Different Species in Humans Allergic to Cow's Milk." Food and Agricultural Immunology 11: 101-111.

Bernard, H., C. Créminon, M. Yvon and J. M. Wal (1998). "Specificity of the human IgE response to the different purified caseins in allergy to cow's milk proteins." Int Arch Allergy Immunol 115: 235-244.

Bonadonna, P., G. Senna and G. Passalacqua (2003). "Dermatological powder as hidden cause of occupational allergy due to casein: a case report." Occup Environ Med 60: 609-610.

Boyano-Martínez, T., C. García-Ara, M. Pedrosa, J. M. Díaz-Pena and S. Quirce (2009). "Accidental allergic reactions in children allergic to cow's milk proteins." Journal of Allergy and Clinical Immunology 123: 883-888.

Bu, G., Y. Luo, F. Chen, K. Liu and T. Zhu (2013). "Milk processing as a tool to reduce cow's milk allergenicity: a mini-review." Dairy Sci Technol 93: 211-223.

Claeys, W. L., S. Cardoen, G. Daube, J. De Block, K. Dewettinck, K. Dierick, L. De Zutter, A. Huyghebaert, H. Imberechts and P. Thiange (2013). "Raw or heated cow milk consumption: Review of risks and benefits." Food control 31: 251-262.

D'Urbano, L. E., K. Pellegrino, M. C. Artesani, S. Donnanno, R. Luciano, C. Riccardi, A. E. Tozzi, L. Rava, F. De Benedetti and G. Cavagni (2010). "Performance of a component-based allergen-microarray in the diagnosis of cow's milk and hen's egg allergy." Clin Exp Allergy 40: 1561-1570.

De Greef, E., B. Hauser, T. Devreker, G. Veereman-Wauters and Y. Vandenplas (2012). "Diagnosis and management of cow's milk protein allergy in infants." World J Pediatr 8: 19-24.

de Silva D, Geromi M, Panesar SS, Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Cardona V, Dubois AEJ, Halken S, Host A, Poulsen LK, Van Ree R, Vlieg-Boerstra BJ, Agache I, S. A and o. b. o. t. E. F. A. a. A. Group (2014). "Acute and Long-term Management of food allergy Systematic Review." Allergy 69: 159-167.

Ehlayel, M., A. Bener, K. Abu Hazeima and F. Al-Mesaifri (2011). "Camel milk is a safer choice than goat milk for feeding children with cow milk allergy." ISRN Allergy 2011: 391641.

Fiocchi, A., J. Brozek, H. Schünemann, S. L. Bahna, A. von Berg, K. Beyer, M. Bozzola, J. Bradsher, E. Compalati, M. Ebisawa, M. A. Guzman, H. Li, R. G. Heine, P. Keith, G. Lack, M. Landi, A. Martelli, F. Rancé, H. Sampson, A. Stein, L. Terracciano and S. Vieths (2010). "World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines." The World Allergy Organization journal 3: 57-161.

Flom, J. D. and S. H. Sicherer (2019). "Epidemiology of Cow's Milk Allergy." Nutrients 11.

Giannetti, A., F. Cipriani, V. Indio, M. Gallucci, C. Caffarelli and G. Ricci (2019). "Influence of Atopic Dermatitis on Cow's Milk Allergy in Children." Medicina (Kaunas) 55.

Gjesing, B., O. Osterballe, B. Schwartz, U. Wahn and H. Løwenstein (1986). "Allergen-specific IgE antibodies against antigenic components in cow milk and milk substitutes." Allergy 41: 51-56.

Grabenhenrich, L. B., S. Dölle, A. Moneret-Vautrin, A. Köhli, L. Lange, T. Spindler, F. Ruëff, K. Nemat, I. Maris and E. Roumpedaki (2016). "Anaphylaxis in children and adolescents: the European Anaphylaxis Registry." Journal of allergy and clinical immunology 137: 1128-1137.

Gupta, R. S., E. E. Springston, M. R. Warrier, B. Smith, R. Kumar, J. Pongracic and J. L. Holl (2011). "The Prevalence, Severity, and Distribution of Childhood Food Allergy in the United States." Pediatrics 128:.

Host, A. (2002). "Frequency of cow's milk allergy in childhood." Ann Allergy Asthma Immunol 89(6 Suppl 1): 33-37.

Huffman, B. (2019). Cow, Encyclopædia Britannica.

Ito, K., M. Futamura, R. Moverare, A. Tanaka, T. Kawabe, T. Sakamoto and M. P. Borres (2012). "The usefulness of casein-specific IgE and IgG4 antibodies in cow's milk allergic children." Clin Mol Allergy 10: 1.

Jeong, K., J. Kim, K. Ahn, S. Y. Lee, T. K. Min, B. Y. Pyun, Y. H. Kim, K. W. Kim, M. H. Sohn, K. E. Kim, G. C. Jang, T. W. Song, J. H. Kim, Y. H. Jeon, Y. J. Lee, Y. M. Park, H. Y. Yum, H. H. Kim, W. K. Kim and S. Lee (2017). "Age-Based Causes and Clinical Characteristics of Immediate-Type Food Allergy in Korean Children." Allergy Asthma Immunol Res 9: 423-430.

Johnke, H., L. A. Norberg, W. Vach, A. Host and K. E. Andersen (2006). "Patterns of sensitization in infants and its relation to atopic dermatitis." Pediatr Allergy Immunol 17: 591-600.

Kaczmarski, M., J. Wasilewska, B. Cudowska, J. Semeniuk, M. Klukowski and E. Matuszewska (2013). "The natural history of cow's milk allergy in north-eastern Poland." Adv Med Sci 58: 22-30.

Katz, Y., N. Rajuan, M. R. Goldberg, E. Eisenberg, E. Heyman, A. Cohen and M. Leshno (2010). "Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy." J Allergy Clin Immunol 126: 77-82.

Kelso, J. M. (2014). "Potential food allergens in medications." J Allergy Clin Immunol 133: 1509-1518; quiz 1519-1520.

Komata, T., L. Soderstrom, M. P. Borres, H. Tachimoto and M. Ebisawa (2007). "The predictive relationship of food-specific serum IgE concentrations to challenge outcomes for egg and milk varies by patient age." J Allergy Clin Immunol 119: 1272-1274.

Kuitunen, M., H. Englund, S. Remes, R. Moverare, A. Pelkonen, M. P. Borres and M. J. Makela (2015). "High IgE levels to alpha-lactalbumin, beta-lactoglobulin and casein predict less successful cow's milk oral immunotherapy." Allergy 70: 955-962.

Kulig, M., R. Bergmann, B. Niggemann, G. Burow and U. Wahn (1998). "Prediction of sensitization to inhalant allergens in childhood: evaluating family history, atopic dermatitis and sensitization to food allergens. The MAS Study Group. Multicentre Allergy Study." Clin Exp Allergy 28: 1397-1403.

Li, J., L. M. Ogorodova, P. A. Mahesh, M. H. Wang, O. S. Fedorova, T. F. Leung, M. Fernandez-Rivas, E. N. C. Mills, J. Potts, I. Kummeling, S. A. Versteeg, R. van Ree, M. Yazdanbakhsh, P. G. J. Burney and G. W. K. Wong (2020). "Comparative Study of Food Allergies in Children from China, India, and Russia: The EuroPrevall-INCO Surveys." J Allergy Clin Immunol Pract 8: 1349-1358.

Linhart, B., R. Freidl, O. Elisyutina, M. Khaitov, A. Karaulov and R. Valenta (2019). "Molecular Approaches for Diagnosis, Therapy and Prevention of Cow s Milk Allergy." Nutrients 11.

Liu, A. H., R. Jaramillo, S. H. Sicherer, R. A. Wood, S. A. Bock, A. W. Burks, M. Massing, R. D. Cohn and D. C. Zeldin (2010). "National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006." J Allergy Clin Immunol 126: 798-806.

Luyt, D., H. Ball, N. Makwana, M. R. Green, K. Bravin, S. M. Nasser, A. T. Clark, A. Standards of Care Committee of the British Society for and I. Clinical (2014). "BSACI guideline for the diagnosis and management of cow's milk allergy." Clin Exp Allergy 44: 642-672.

Manuyakorn, W. and P. Tanpowpong (2019). "Cow milk protein allergy and other common food allergies and intolerances." Paediatrics and International Child Health 39: 32-40.

Martorell-Aragonés, A., L. Echeverría-Zudaire, E. Alonso-Lebrero, J. Boné-Calvo, M. F. Martín-Muñoz, S. Nevot-Falcó, M. Piquer-Gibert and L. Valdesoiro-Navarrete (2015). "Position document: IgE-mediated cow's milk allergy." Allergol Immunopathol (Madr) 43: 507-526.

Matsuo, H., T. Yokooji and T. Taogoshi (2015). "Common food allergens and their IgE-binding epitopes." Allergol Int 64: 332-343.

Muthukumar, J., P. Selvasekaran, M. Lokanadham and R. Chidambaram (2020). "Food and food products associated with food allergy and food intolerance - An overview." Food Res Int 138(Pt B): 109780.

Nantanee, R., N. Suratannon and P. Chatchatee (2022). "Characteristics and Laboratory Findings of Food-Induced Anaphylaxis in Children: Study in an Asian Developing Country." International Archives of Allergy and Immunology 183: 59-67.

Nwaru, B. I., L. Hickstein, S. S. Panesar, G. Roberts, A. Muraro, A. Sheikh, E. F. Allergy and G. Anaphylaxis Guidelines (2014). "Prevalence of common food allergies in Europe: a systematic review and meta-analysis." Allergy 69: 992-1007.

Pajno, G. B., M. Fernandez-Rivas, S. Arasi, G. Roberts, C. A. Akdis, M. Alvaro-Lozano, K. Beyer, C. Bindslev-Jensen, W. Burks, M. Ebisawa, P. Eigenmann, E. Knol, K. C. Nadeau, L. K. Poulsen, R. van Ree, A. F. Santos, G. du Toit, S. Dhami, U. Nurmatov, Y. Boloh, M. Makela, L. O'Mahony, N. Papadopoulos, C. Sackesen, I. Agache, E. Angier, S. Halken, M. Jutel, S. Lau, O. Pfaar, D. Ryan, G. Sturm, E. M. Varga, R. G. van Wijk, A. Sheikh, A. Muraro and E. A. I. G. Group (2018). "EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy." Allergy 73: 799-815.

Panel, N. I.-S. E., J. A. Boyce, A. Assa'ad, A. W. Burks, S. M. Jones, H. A. Sampson, R. A. Wood, M. Plaut, S. F. Cooper, M. J. Fenton, S. H. Arshad, S. L. Bahna, L. A. Beck, C. Byrd-Bredbenner, C. A. Camargo, Jr., L. Eichenfield, G. T. Furuta, J. M. Hanifin, C. Jones, M. Kraft, B. D. Levy, P. Lieberman, S. Luccioli, K. M. McCall, L. C. Schneider, R. A. Simon, F. E. Simons, S. J. Teach, B. P. Yawn and J. M. Schwaninger (2010). "Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel." J Allergy Clin Immunol 126(6 Suppl): S1-58.

Petrosino, M. I., A. Scaparrotta, M. L. Marcovecchio, D. Panichi, D. Rapino, M. Attanasi, P. D. Filippo, S. D. Pillo and F. Chiarelli (2018). "Usefulness of molecular diagnosis in egg allergic children." Arch Med Sci 14: 132-137.

Pouessel, G., P. J. Turner, M. Worm, V. Cardona, A. Deschildre, E. Beaudouin, J. M. Renaudin, P. Demoly and L. K. Tanno (2018). "Food‐induced fatal anaphylaxis: from epidemiological data to general prevention strategies." Clinical & Experimental Allergy 48: 1584-1593.

Rautiainen, J., S. Auriola, J. Rouvinen, J. Kauppinen, T. Zeiler, D. Novikov, T. Virtanen and R. A. Mantyjarvi (1998). "Molecular and crystal properties of Bos d 2, an allergenic protein of the lipocalin family." Biochem Biophys Res Commun 247: 746-750.

Rautiainen, J., M. Rytkonen, S. Parkkinen, J. Pentikainen, A. Linnala-Kankkunen, T. Virtanen, J. Pelkonen and R. Mantyjarvi (1995). "cDNA cloning and protein analysis of a bovine dermal allergen with homology to psoriasin." J Invest Dermatol 105: 660-663.

Restani, P., C. Ballabio, C. Di Lorenzo, S. Tripodi and A. Fiocchi (2009). "Molecular aspects of milk allergens and their role in clinical events." Anal Bioanal Chem 395: 47-56.

Sackesen, C., D. U. Altintas, A. Bingol, G. Bingol, B. Buyuktiryaki, E. Demir, A. Kansu, Z. Kuloglu, Z. Tamay and B. E. Sekerel (2019). "Current Trends in Tolerance Induction in Cow's Milk Allergy: From Passive to Proactive Strategies." Front Pediatr 7: 372.

Sampson, H. A., S. Aceves, S. A. Bock, J. James, S. Jones, D. Lang, K. Nadeau, A. Nowak-Wegrzyn, J. Oppenheimer, T. T. Perry, C. Randolph, S. H. Sicherer, R. A. Simon, B. P. Vickery, R. Wood, P. Joint Task Force on Practice, D. Bernstein, J. Blessing-Moore, D. Khan, D. Lang, R. Nicklas, J. Oppenheimer, J. Portnoy, C. Randolph, D. Schuller, S. Spector, S. A. Tilles, D. Wallace, W. Practice Parameter, H. A. Sampson, S. Aceves, S. A. Bock, J. James, S. Jones, D. Lang, K. Nadeau, A. Nowak-Wegrzyn, J. Oppenheimer, T. T. Perry, C. Randolph, S. H. Sicherer, R. A. Simon, B. P. Vickery and R. Wood (2014). "Food allergy: a practice parameter update-2014." J Allergy Clin Immunol 134: 1016-1025.

Santoro, A., L. Andreozzi, G. Ricci, C. Mastrorilli and C. Caffarelli (2019). "Allergic reactions to cow's milk proteins in medications in childhood." Acta Biomed 90(3-S): 91-93.

Santos, A., A. Dias and J. A. Pinheiro (2010). "Predictive factors for the persistence of cow’s milk allergy." Pediatric allergy and immunology 21: 1127-1134.

Schoemaker, A. A., A. B. Sprikkelman, K. E. Grimshaw, G. Roberts, L. Grabenhenrich, L. Rosenfeld, S. Siegert, R. Dubakiene, O. Rudzeviciene, M. Reche, A. Fiandor, N. G. Papadopoulos, A. Malamitsi-Puchner, A. Fiocchi, L. Dahdah, S. T. Sigurdardottir, M. Clausen, A. Stańczyk-Przyłuska, K. Zeman, E. N. Mills, D. McBride, T. Keil and K. Beyer (2015). "Incidence and natural history of challenge-proven cow's milk allergy in European children--EuroPrevall birth cohort." Allergy 70: 963-972.

Sicherer, S. H. (2011). "Epidemiology of food allergy." Journal of Allergy and Clinical Immunology 127: 594-602.

Skripak, J. M., E. C. Matsui, K. Mudd and R. A. Wood (2007). "The natural history of IgE-mediated cow's milk allergy." J Allergy Clin Immunol 120: 1172-1177.

Suh, J., H. Lee, J. H. Lee, J. Cho, J. S. Yu, J. Kim, Y. Han, K. Ahn and S. I. Lee (2011). "Natural course of cow's milk allergy in children with atopic dermatitis." J Korean Med Sci 26: 1152-1158.

Taniuchi, S., M. Takahashi, K. Soejima, Y. Hatano and H. Minami (2017). "Immunotherapy for cow's milk allergy." Human vaccines & immunotherapeutics 13: 2443-2451.

Tedner, G., S. Cilla, K. Jon, B. K. Eline, B. Magnus, C. Kal-Hakon and e. al. (2021). "Extract and molecular-based early infant sensitization and associated factors – a PreventADALL study." Allergy (ahead of print).

Tsabouri, S., K. Douros and K. N. Priftis (2014). "Cow's milk allergenicity." Endocr Metab Immune Disord Drug Targets 14: 16-26.

Venkataraman, D., M. Erlewyn-Lajeunesse, R. J. Kurukulaaratchy, S. Potter, G. Roberts, S. Matthews and S. H. Arshad (2018). "Prevalence and longitudinal trends of food allergy during childhood and adolescence: Results of the Isle of Wight Birth Cohort study." Clin Exp Allergy 48: 394-402.

Venter, C., T. Brown, R. Meyer, J. Walsh, N. Shah, A. Nowak-Wegrzyn, T. X. Chen, D. M. Fleischer, R. G. Heine, M. Levin, M. C. Vieira and A. T. Fox (2017). "Better recognition, diagnosis and management of non-IgE-mediated cow's milk allergy in infancy: iMAP-an international interpretation of the MAP (Milk Allergy in Primary Care) guideline." Clin Transl Allergy 7: 26.

Verduci, E., S. D'Elios, L. Cerrato, P. Comberiati, M. Calvani, S. Palazzo, A. Martelli, M. Landi, T. Trikamjee and D. G. Peroni (2019). "Cow's Milk Substitutes for Children: Nutritional Aspects of Milk from Different Mammalian Species, Special Formula and Plant-Based Beverages." Nutrients 11.

Verhoeckx, K. C. M., Y. M. Vissers, J. L. Baumert, R. Faludi, M. Feys, S. Flanagan, C. Herouet-Guicheney, T. Holzhauser, R. Shimojo, N. van der Bolt, H. Wichers and I. Kimber (2015). "Food processing and allergenicity." Food Chem Toxicol 80: 223-240.

Vila, L., K. Beyer, K. M. Jarvinen, P. Chatchatee, L. Bardina and H. A. Sampson (2001). "Role of conformational and linear epitopes in the achievement of tolerance in cow's milk allergy." Clin Exp Allergy 31: 1599-1606.

Villa, C., J. Costa, M. B. P. P. Oliveira and I. Mafra (2018). "Bovine Milk Allergens: A Comprehensive Review." Comprehensive Reviews in Food Science and Food Safety 17: 137-164.

Visioli, F. and A. Strata (2014). "Milk, dairy products, and their functional effects in humans: a narrative review of recent evidence." Adv Nutr 5: 131-143.

Wal, J.-M. (2002). "Cow's milk proteins/allergens." Annals of Allergy, Asthma & Immunology 89(6, Supplement): 3-10.

Walsh, J., R. Meyer, N. Shah, J. Quekett and A. T. Fox (2016). "Differentiating milk allergy (IgE and non-IgE mediated) from lactose intolerance: understanding the underlying mechanisms and presentations." Br J Gen Pract 66: -611.

WHO/IUIS. (2019). "Allergen 'Bos d 3'." Retrieved 01.03.21, from http://www.allergen.org/viewallergen.php?aid=161.

WHO/IUIS. (2020). "Allergen 'Bos d 2'." Retrieved 01.03.2021, from http://www.allergen.org/viewallergen.php?aid=160.

WHO/IUIS. (2020). "Allergen Nomenclature 'Bos domesticus'." Retrieved 01.03.2021, from http://www.allergen.org/search.php?allergenname=&allergensource=Bos+domesticus+%28Bos+taurus%29&TaxSource=&TaxOrder=&foodallerg=all&bioname=.

Zajác, P., J. Čapla, V. Vietoris, S. Zubrická and J. Čurlej (2015). "Effects of storage on the major constituents of raw milk." Potravinarstvo Slovak Journal of Food Sciences 9: 375-381.